Skip to main content

Biren Amin

Stock Analyst at Piper Sandler

Total Price Targets
17
Stocks Covered
12
Sectors
Healthcare
Most Recent
Feb 19, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • CATX+218.1%
    Perspective Therapeutics, Inc.
    $16.00 targetFeb 19, 2026
  • BBOT+116.5%
    BridgeBio Oncology Therapeutics Inc.
    $21.00 targetAug 15, 2025
  • MNPR+30.7%
    Monopar Therapeutics Inc.
    $95.00 targetSep 25, 2025

Most Bearish

  • SRPT-31.8%
    Sarepta Therapeutics, Inc.
    $16.00 targetOct 30, 2025
  • MNPR+30.7%
    Monopar Therapeutics Inc.
    $95.00 targetSep 25, 2025
  • BBOT+116.5%
    BridgeBio Oncology Therapeutics Inc.
    $21.00 targetAug 15, 2025

Stocks Covered by Biren Amin

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
CATXPerspective Therapeutics, Inc.$16.00$3.90+310.8%1Feb 19, 2026
SRPTSarepta Therapeutics, Inc.$16.00$21.60-25.9%5Oct 30, 2025
MNPRMonopar Therapeutics Inc.$95.00$53.02+79.2%1Sep 25, 2025
BBOTBridgeBio Oncology Therapeutics Inc.$21.00$8.36+151.2%1Aug 15, 2025
LENZLENZ Therapeutics, Inc.$51.00$8.85+476.6%1Apr 14, 2025
VKTXViking Therapeutics, Inc.$74.00$29.80+148.3%1Dec 2, 2024
ACLXArcellx, Inc.$115.00$115.07-0.1%2Nov 8, 2024
BBIOBridgeBio Pharma, Inc.$46.00$69.25-33.6%1Sep 11, 2024
IMNMImmunome, Inc.$23.00$22.80+0.9%1Aug 13, 2024
OCULOcular Therapeutix, Inc.$15.00$9.46+58.5%1Jun 27, 2024
SLDBSolid Biosciences Inc.$20.00$7.14+179.9%1May 31, 2024
ALLOAllogene Therapeutics, Inc.$30.00$2.15+1298.6%1Oct 8, 2021

Recent Activity

  • Feb 19, 2026— Set$16.00price target onCATX(Perspective Therapeutics, Inc.)
  • Oct 30, 2025— Set$16.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Sep 25, 2025— Set$95.00price target onMNPR(Monopar Therapeutics Inc.)
  • Aug 15, 2025— Set$21.00price target onBBOT(BridgeBio Oncology Therapeutics Inc.)
  • Apr 14, 2025— Set$51.00price target onLENZ(LENZ Therapeutics, Inc.)
  • Dec 2, 2024— Set$74.00price target onVKTX(Viking Therapeutics, Inc.)
  • Nov 27, 2024— Set$182.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Nov 8, 2024— Set$115.00price target onACLX(Arcellx, Inc.)
  • Sep 11, 2024— Set$46.00price target onBBIO(BridgeBio Pharma, Inc.)
  • Aug 13, 2024— Set$23.00price target onIMNM(Immunome, Inc.)
  • Aug 8, 2024— Set$200.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Jun 27, 2024— Set$15.00price target onOCUL(Ocular Therapeutix, Inc.)
  • Jun 26, 2024— Set$205.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Jun 13, 2024— Set$157.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • May 31, 2024— Set$20.00price target onSLDB(Solid Biosciences Inc.)
  • May 31, 2024— Set$70.00price target onACLX(Arcellx, Inc.)
  • Oct 8, 2021— Set$30.00price target onALLO(Allogene Therapeutics, Inc.)

Frequently Asked Questions

Who is Biren Amin?

Biren Amin is a stock analyst at Piper Sandler covering 12 stocks primarily in Healthcare. They have issued 17 price targets since Oct 8, 2021.

What stocks does Biren Amin cover?

Biren Amin currently covers 12 stocks, including SRPT, ACLX, CATX, MNPR, BBOT.

What is Biren Amin's latest price target?

Biren Amin's most recent price target was $16.00 on CATX (Perspective Therapeutics, Inc.), set on Feb 19, 2026.

What is Biren Amin's highest price target?

Biren Amin's highest issued price target is $205.00 on SRPT, set on Jun 26, 2024.

Coverage based on publicly published price targets. Not investment advice.